Presentation is loading. Please wait.

Presentation is loading. Please wait.

Pulmonary large cell neuroendocrine carcinoma demonstrates high proliferative activity  Akira Iyoda, MD, Kenzo Hiroshima, MD, Yasumitsu Moriya, MD, Teruaki.

Published byMatilde Huber Modified over 5 years ago

Similar presentations

Presentation on theme: "Pulmonary large cell neuroendocrine carcinoma demonstrates high proliferative activity  Akira Iyoda, MD, Kenzo Hiroshima, MD, Yasumitsu Moriya, MD, Teruaki."— Presentation transcript:

1 Pulmonary large cell neuroendocrine carcinoma demonstrates high proliferative activity 
Akira Iyoda, MD, Kenzo Hiroshima, MD, Yasumitsu Moriya, MD, Teruaki Mizobuchi, MD, Mizuto Otsuji, MD, Yasuo Sekine, MD, Kiyoshi Shibuya, MD, Toshihiko Iizasa, MD, Yukio Saitoh, MD, Takehiko Fujisawa, MD  The Annals of Thoracic Surgery  Volume 77, Issue 6, Pages (June 2004) DOI: /j.athoracsur

2 Fig 1 Immunohistochemical staining for anti Ki-67 antibody in large cell neuroendocrine carcinoma. (×40). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )

3 Fig 2 Immunohistochemical staining for anti Ki-67 antibody in classic large cell carcinoma. (×40). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )

4 Fig 3 Immunohistochemical staining for anti P53 protein antibody in large cell neuroendocrine carcinoma. (×40). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )

5 Fig 4 Immunohistochemical staining for anti P53 protein antibody in classic large cell carcinoma. (×40). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )

6 Fig 5 Immunohistochemical staining for anti Bcl-2 antibody in large cell neuroendocrine carcinoma. (×40). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )

7 Fig 6 Immunohistochemical staining for anti Bcl-2 antibody in classic large cell carcinoma. (×40). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )

8 Fig 7 The disease specific disease-free survival analysis indicates that LCNEC cases with stage 1 disease had a significantly poorer prognosis than CLCC cases with stage 1 disease. (LCNEC = large cell neuroendocrine carcinoma; CLCC = classic large cell carcinoma.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )

9 Fig 8 The disease specific disease-free survival analysis indicates that LCNEC cases without adjuvant chemotherapy had a significantly poorer prognosis than CLCC cases without adjuvant chemotherapy. (LCNEC = large cell neuroendocrine carcinoma; CLCC = classic large cell carcinoma.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )

Download ppt "Pulmonary large cell neuroendocrine carcinoma demonstrates high proliferative activity  Akira Iyoda, MD, Kenzo Hiroshima, MD, Yasumitsu Moriya, MD, Teruaki."

Similar presentations

Neuroendocrine and biologic features of primary tumors and tissue in pulmonary large cell carcinomas  Alexandre M Ab' Saber, MD, Ledo Mazzei Massoni Neto,

Neuroendocrine and biologic features of primary tumors and tissue in pulmonary large cell carcinomas  Alexandre M Ab' Saber, MD, Ledo Mazzei Massoni Neto,
A Propensity-Matched Analysis of Wedge Resection and Stereotactic Body Radiotherapy for Early Stage Lung Cancer  Jeffrey L. Port, MD, Bhupesh Parashar,

A Propensity-Matched Analysis of Wedge Resection and Stereotactic Body Radiotherapy for Early Stage Lung Cancer  Jeffrey L. Port, MD, Bhupesh Parashar,
Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.

Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.
Thomas J. Birdas, MD, Richard P. M

Thomas J. Birdas, MD, Richard P. M
Comparison of Thoracoscopic Segmentectomy and Thoracoscopic Lobectomy for Small-Sized Stage IA Lung Cancer  Chenxi Zhong, MD, Wentao Fang, MD, Teng Mao,

Comparison of Thoracoscopic Segmentectomy and Thoracoscopic Lobectomy for Small-Sized Stage IA Lung Cancer  Chenxi Zhong, MD, Wentao Fang, MD, Teng Mao,
Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study  Massimiliano Paci, MD, Alberto Cavazza, MD, Valerio.

Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study  Massimiliano Paci, MD, Alberto Cavazza, MD, Valerio.
E-cadherin expression associated with differentiation and prognosis in patients with non–small cell lung cancer  Dage Liu, MD, Cheng-long Huang, MD, Kotaro.

E-cadherin expression associated with differentiation and prognosis in patients with non–small cell lung cancer  Dage Liu, MD, Cheng-long Huang, MD, Kotaro.
Rodrigo A. S. Sardenberg, MD, Clovis Pinto, MD, Cynthia A

Rodrigo A. S. Sardenberg, MD, Clovis Pinto, MD, Cynthia A
Minimal alteration of pulmonary function after lobectomy in lung cancer patients with chronic obstructive pulmonary disease  Yasuo Sekine, MD, Takekazu.

Minimal alteration of pulmonary function after lobectomy in lung cancer patients with chronic obstructive pulmonary disease  Yasuo Sekine, MD, Takekazu.
Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.

Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.
Prediction of Prognosis and Surgical Indications for Pulmonary Metastasectomy From Colorectal Cancer  Toshihiko Iizasa, MD, Makoto Suzuki, MD, Shigetoshi.

Prediction of Prognosis and Surgical Indications for Pulmonary Metastasectomy From Colorectal Cancer  Toshihiko Iizasa, MD, Makoto Suzuki, MD, Shigetoshi.
Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers  Yung-Chie Lee, MD, PhD, Yih-Leong Chang, MD, Shi-Ping.

Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers  Yung-Chie Lee, MD, PhD, Yih-Leong Chang, MD, Shi-Ping.
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Adjuvant Chemotherapy with 5-Fluorouracil and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma  Jeeyun Lee, MD, Kyoung-Eun.

Adjuvant Chemotherapy with 5-Fluorouracil and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma  Jeeyun Lee, MD, Kyoung-Eun.
Prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung  Kenzo Hiroshima, MD, Akira Iyoda, MD, Kiyoshi Shibuya, MD, Tetsuya.

Prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung  Kenzo Hiroshima, MD, Akira Iyoda, MD, Kiyoshi Shibuya, MD, Tetsuya.
Is the Myofibrillarlytic Myocyte a Forme Fruste Apoptotic Myocyte?

Is the Myofibrillarlytic Myocyte a Forme Fruste Apoptotic Myocyte?
Immunohistochemical studies of pulmonary large cell neuroendocrine carcinoma: A possible association between staining patterns with neuroendocrine markers.

Immunohistochemical studies of pulmonary large cell neuroendocrine carcinoma: A possible association between staining patterns with neuroendocrine markers.
Epidermal Growth Factor Receptor Is a Prognosis Predictor in Patients With Esophageal Squamous Cell Carcinoma  Wencheng Zhang, MD, Hongxia Zhu, MD, Xiao.

Epidermal Growth Factor Receptor Is a Prognosis Predictor in Patients With Esophageal Squamous Cell Carcinoma  Wencheng Zhang, MD, Hongxia Zhu, MD, Xiao.
Tumor Angiogenesis as a Prognostic Marker in Operable Non–Small Cell Lung Cancer  Katsuhiko Matsuyama, Yukio Chiba, Masato Sasaki, Hirokazu Tanaka, Ryusuke.

Tumor Angiogenesis as a Prognostic Marker in Operable Non–Small Cell Lung Cancer  Katsuhiko Matsuyama, Yukio Chiba, Masato Sasaki, Hirokazu Tanaka, Ryusuke.
Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Similar presentations

Ads by Google